Neoadjuvant Atezolizumab in Cutaneous Melanoma

Summary

The purpose of this research study is to see whether using atezolizumab before surgery is safe and does not cause side effects that delay surgery in participants with cutaneous melanoma that has not spread to other areas of the body (non-metastatic) and can be removed by surgery (resectable) but has a higher risk of coming back after surgery (high-risk).

Timeline

Start

2020-09-25

Primary completion

2025-10-01

Completion

2026-10-01

Drugs

Indications